Enanta Pharmaceuticals Ownership | Who Owns Enanta Pharmaceuticals?
Enanta Pharmaceuticals Ownership Summary
Enanta Pharmaceuticals is owned by 39.30% institutional investors, 4.69% insiders, and 56.00% retail investors. Vanguard group is the largest institutional shareholder, holding 10.77% of ENTA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.95% of its assets in Enanta Pharmaceuticals shares.
ENTA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Enanta Pharmaceuticals | 39.30% | 4.69% | 56.00% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 2.30M | 10.77% | $36.30M |
| Blackrock funding, inc. /de | 3.08M | 10.70% | $48.51M |
| Farallon capital management | 2.12M | 9.95% | $25.40M |
| Krensavage asset management | 2.11M | 9.92% | $25.31M |
| Blackrock | 1.85M | 8.72% | $23.96M |
| Millennium management | 1.35M | 6.33% | $7.44M |
| Commodore capital lp | 800.00K | 3.75% | $9.58M |
| Acadian asset management | 885.13K | 3.08% | $13.95M |
| Bank of america corp /de/ | 595.91K | 2.81% | $7.73M |
| Geode capital management | 645.79K | 2.25% | $10.19M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Krensavage asset management | 2.11M | 10.78% | $25.31M |
| Stonepine capital management | 305.00K | 2.97% | $3.65M |
| Commodore capital lp | 800.00K | 0.47% | $9.58M |
| Pharvision advisers | 35.85K | 0.24% | $429.08K |
| Hillsdale investment management | 422.30K | 0.18% | $6.66M |
| Stempoint capital lp | 75.19K | 0.18% | $900.07K |
| Farallon capital management | 2.12M | 0.10% | $25.40M |
| Eam investors | 40.95K | 0.07% | $645.81K |
| Pdt partners | 86.02K | 0.06% | $1.03M |
| Tang capital management | 126.66K | 0.06% | $1.52M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 3.08M | 0.00% | 1.24M |
| Commodore capital lp | 800.00K | 0.47% | 800.00K |
| Millennium management | 1.35M | 0.00% | 449.94K |
| Hillsdale investment management | 422.30K | 0.18% | 422.30K |
| Vanguard group | 2.30M | 0.00% | 362.96K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -1.04M |
| Armistice capital | - | - | -1.00M |
| Soleus capital management | - | - | -785.55K |
| Marshall wace, llp | 275.39K | 0.00% | -582.02K |
| Stonepine capital management | 305.00K | 2.97% | -299.07K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Commodore capital lp | 800.00K | 0.47% | 800.00K | $9.58M |
| Hillsdale investment management | 422.30K | 0.18% | 422.30K | $6.66M |
| Point72 asset management | 300.00K | 0.01% | 300.00K | $3.59M |
| Stempoint capital lp | 75.19K | 0.18% | 75.19K | $900.07K |
| Panagora asset management | 66.99K | 0.00% | 66.99K | $1.06M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Innealta capital | -16.00 |
| Voisard asset management group | -28.00 |
| Quadrant capital group | -35.00 |
| Raymond james financial | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 53 | -57.94% | 8,402,898 | -55.75% | 39 | 0.50% | 30 | -50.82% | 11 | -72.50% |
| Sep 30, 2025 | 47 | -53.00% | 5,407,827 | -68.64% | 25 | 0.39% | 20 | -55.56% | 17 | -55.26% |
| Jun 30, 2025 | 104 | -5.45% | 18,326,590 | -1.61% | 85 | 1.12% | 47 | -16.07% | 41 | 10.81% |
| Mar 31, 2025 | 5 | -95.33% | 2,149,611 | -88.86% | 10 | 0.12% | 2 | -96.61% | 1 | -96.55% |
| Dec 31, 2024 | 32 | -71.17% | 5,786,937 | -72.69% | 27 | 0.27% | 17 | -69.09% | 9 | -71.88% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 629.60K | 2.95% | - |
| Vanguard Total Stock Mkt Idx Inv | 852.43K | 2.94% | 21.55K |
| iShares Russell 2000 ETF | 660.36K | 2.28% | 235.73K |
| BlackRock Health Sciences Opps Inv A | 495.69K | 1.71% | 438.53K |
| Columbia Small Cap Value I A | 271.73K | 1.28% | 3.30K |
| Hillsdale US Small Cap Eq Fund Srs A U$ | 352.70K | 1.22% | 352.70K |
| Vanguard Strategic Small-Cap Equity Inv | 317.24K | 1.09% | -20.86K |
| Vanguard Institutional Extnd Mkt Idx Tr | 285.64K | 0.98% | 1.62K |
| Columbia Small Cap Value I | 200.68K | 0.95% | 200.68K |
| iShares Russell 2000 Value ETF | 240.10K | 0.83% | 67.34K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 05, 2025 | Capps Kathleen S. | See Remarks | Sell | $4.60K |
| Dec 05, 2025 | Trout Harry R. III | See Remarks | Sell | $7.71K |
| Dec 05, 2025 | Rottinghaus Scott T. | Chief Medical Officer | Sell | $11.36K |
| Dec 05, 2025 | Luu Brendan | Chief Business Officer | Sell | $19.84K |
| Dec 05, 2025 | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell | $29.97K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | 9 |
| 2025 Q3 | - | - |
| 2025 Q1 | 1 | - |
| 2024 Q4 | - | 6 |
ENTA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools